n.kravchenko
TL2 · Enugu
Contributes reviews on supplier material. Based in Enugu.
Joined 10 April 2025 · last posted 1d
81 posts, newest first. Showing up to 150.
-
What "marked as solution" means and who gets to mark it Replied, post #3 · marked as the solution · Start Here › Welcome · 27 Jul 2026 · 9 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Impurity thresholds: where the common numbers come from Replied, post #16 · Analytics › Impurities & related substances · 26 Jul 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Tracking intake honestly when appetite is absent Replied, post #115 · Nutrition & Training › Protein & intake · 26 Jul 2026 · 23 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Why the Start Here categories exist, and what they are not for Replied, post #28 · Start Here › Welcome · 23 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #51 · Practice › Interactions · 21 Jul 2026 · 21 likes Post #50 is the version of this I will quote in future. One addition. Food interactions: most interactions are absorption interactions. Some medications absorb better…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #71 · Evidence › Journal club · 20 Jul 2026 · 20 likes Before the thread moves on from STEP 1 — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #90 · Analytics › Impurities & related substances · 18 Jul 2026 · 7 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #64 · Access › Insurance & coverage · 9 Jul 2026 · 4 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #3 · Clinical › Comorbidities · 8 Jul 2026 · 19 likes The useful distinction on Osteoarthritis and mechanical versus metabolic is between what was measured and what was inferred from it. Both end up in the same sentence…
-
Substitution between formats during a shortage — what changed since Replied, post #4 · Access › Shortages · 8 Jul 2026 · 14 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #44 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 3 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once. That is my…
-
Follow-up: Sleep quality changes during weight loss Replied, post #53 · Wellbeing › Sleep · 25 Jun 2026 · 0 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #109 · Access › Insurance & coverage · 16 Jun 2026 · 27 likes Adding a data point of agreement rather than a data point.
-
Follow-up: External review after an internal denial Replied, post #5 · Access › Insurance & coverage · 15 Jun 2026 · 13 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #59 · Access › Pricing · 9 Jun 2026 · 4 likes Something worth flagging about comparing prices across jurisdictions: the strongest-sounding claims in this thread are the ones with no source attached, which is the…
-
Official shortage notices and what they authorise Replied, post #63 · Access › Shortages · 22 May 2026 · 6 likes Narrowing post #62, because the general version has more than one answer. International supply chains: a shortage in one country does not mean shortage in another. That…
-
What a certificate commits its issuer to — one year on Replied, post #67 · Analytics › COA interpretation · 13 May 2026 · 0 likes This follows post #66 rather than contradicting it. A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined…
-
Electrolyte supplements: which ones do anything Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 5 May 2026 · 0 likes The opening post describes the usual case. This is about the unusual one. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #108 · Compounds › Tirzepatide · 3 May 2026 · 0 likes Having read the whole 2.5 mg starting dose thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
Primary endpoint hierarchies and why order matters Replied, post #5 · Evidence › Trials · 3 May 2026 · 22 likes I read the opening post twice before replying, because I had assumed the opposite. Registration before enrolment, with the primary endpoint declared, is what makes…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #81 · Devices › Syringes & needles · 2 May 2026 · 3 likes Picking up post #78: that is the part I would want checked first. Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same…
-
GLP-1 receptor distribution: central and peripheral Replied, post #32 · Pharmacology › Receptor biology · 15 Apr 2026 · 25 likes Narrowing post #31, because the general version has more than one answer. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
-
Reflux appearing for the first time at a dose step Replied, post #5 · Practice › Side effects · 12 Apr 2026 · 2 likes Gastrointestinal effects in this class are dose-related and escalation-related. Both are true simultaneously, which is why symptoms typically return at each step and…
-
Micro-titration: a disputed topic, argued properly Replied, post #57 · Practice › Dosing & titration · 8 Apr 2026 · 4 likes Post #54 is the version of this I will quote in future. One addition. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #18 · Practice › Interactions · 30 Mar 2026 · 29 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. I would treat…
-
About the Doc review category Replied, post #4 · Documentation › Doc review · 24 Mar 2026 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Follow-up: Search filters: what is missing Replied, post #52 · Meta › Site feedback · 13 Mar 2026 · 7 likes Marking my uncertainty on Search filters explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #39 · Analytics › Impurities & related substances · 25 Feb 2026 · 1 like Peptide impurities that differ by a single residue are the hardest to resolve and the most likely to be biologically relevant, which is an unfortunate combination.
-
Request: export my own posts — one year on Replied, post #51 · Meta › Feature requests · 24 Feb 2026 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Coverage in the US: a map of the usual obstacles Replied, post #46 · Regional › North America · 4 Feb 2026 · 9 likes Building on post #45 rather than restating it. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #59 · Regional › UK & Ireland · 12 Jan 2026 · 0 likes Adding the measurement that post #57 says would settle it. Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory…
-
A partial dose because the pen emptied mid-injection Replied, post #77 · Practice › Administration · 9 Jan 2026 · 14 likes What I would check first on partial dose because the pen is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #5 · Sourcing › Vendor reports · 1 Jan 2026 · 14 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds. Someone should write this up…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #128 · Practice › Reconstitution · 26 Dec 2025 · 16 likes Building on post #125 rather than restating it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #28 · Compounds › Tirzepatide · 4 Dec 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #24 · Devices › Pens & autoinjectors · 2 Dec 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #46 · Analytics › Impurities & related substances · 23 Nov 2025 · 3 likes The strongest argument against my own position on Aggregates, stated as well as I can state it, since nobody else has yet.
-
Personal import allowances, compared — a second dataset Replied, post #25 · Access › International · 21 Nov 2025 · 1 like I read post #23 twice before replying, because I had assumed the opposite. Adding a small correction to the Personal import allowances summary above rather than a…
-
Sleep quality changes during weight loss — what changed since Replied, post #56 · Wellbeing › Sleep · 9 Nov 2025 · 4 likes Energy availability affects sleep in both directions, and a large deficit can produce either fragmentation or unusual sleepiness. Flagging that the sources on this are…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #82 · Documentation › Doc review · 27 Oct 2025 · 23 likes Where I would push back on the Promotion criteria consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
A 40-week log with the measurement method stated Replied, post #59 · Outcomes › Progress reports · 23 Oct 2025 · 6 likes The bit of 40-week log that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #93 · Practice › Storage & stability · 20 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. A partial answer,…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #34 · Practice › Interactions · 18 Oct 2025 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. It is worth…
-
A preprint whose numbers changed substantially at publication Replied, post #86 · Evidence › Preprints · 10 Oct 2025 · 1 like Narrowing post #84, because the general version has more than one answer. A preprint with the data and code attached is frequently more checkable than a published paper…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #8 · Practice › Storage & stability · 5 Oct 2025 · 30 likes Counterpoint on Storing lyophilised material long term, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #113 · Practice › Side effects · 2 Oct 2025 · 10 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #15 · Evidence › Preprints · 26 Sep 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #6 · Evidence › Preprints · 25 Sep 2025 · 3 likes I came in to disagree and I am leaving without a disagreement.
-
Where impurities in solid-phase peptide synthesis come from Replied, post #5 · Analytics › Impurities & related substances · 30 Aug 2025 · 0 likes Worth separating two things that the opening post runs together. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
A request that was declined, and the reasoning — a second dataset Replied, post #49 · Documentation › Wiki requests · 10 Aug 2025 · 5 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. That is the version I use. It may…
-
Preparing for an appointment: one page, three questions Replied, post #29 · Clinical › Prescriber conversations · 28 Jul 2025 · 13 likes Prescribers reading this subcategory consistently say the most difficult consultations are the ones where information is withheld rather than the ones with difficult…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #79 · Outcomes › Progress reports · 13 Jul 2025 · 32 likes Noted, and I have changed what I was going to do on the strength of it.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #68 · Clinical › Comorbidities · 9 Jul 2025 · 33 likes I would rather this thread reach "we do not know" about Cardiovascular risk than reach a confident answer that nobody can support when asked.
-
Coming back to: When "no data" is the complete and final answer Replied, post #22 · Compounds › Other compounds · 23 Jun 2025 · 0 likes Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for that form is usually the single most useful document available and is…
-
Counter-ion content and its effect on measured mass Replied, post #68 · Analytics › Mass spectrometry · 18 Jun 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Half-life, steady state, and accumulation worked through Replied, post #110 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 9 likes Two questions I would want answered before drawing anything from the half-life data above: how were the cases selected, and what happened to the ones that dropped out.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #111 · Clinical › Comorbidities · 11 Jun 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #36 · Access › Insurance & coverage · 9 Jun 2025 · 12 likes This follows post #35 rather than contradicting it. A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because…
-
Sequence verification for an obscure compound: how it is done Replied, post #52 · Compounds › Other compounds · 3 Jun 2025 · 10 likes My experience of sequence verification contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #4 · Sourcing › Vendor reports · 21 May 2025 · 1 like Counterpoint on vendor documentation pages, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #95 · Sourcing › Red flags · 14 May 2025 · 8 likes I had written a reply contradicting post #94 and deleted it. Here is what survived. The guidelines draw that line for a practical reason as much as a fair one: reports…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #16 · Evidence › Trials · 23 Apr 2025 · 3 likes One caution on Comparators chosen for regulatory reasons: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #93 · Evidence › Journal club · 9 Apr 2025 · 0 likes This follows post #90 rather than contradicting it. An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #67 · Practice › Reconstitution · 31 Mar 2025 · 30 likes Something worth flagging about 5 mg vial: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #125 · Pharmacology › Receptor biology · 19 Mar 2025 · 28 likes Fair, and the limits you put on it are the part I will remember.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #77 · Sourcing › Vendor reports · 17 Mar 2025 · 16 likes Recording a reorder result against the original is one of the highest-value contributions here, because consistency over time is what a single result cannot show.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #59 · Sourcing › Regulatory · 2 Mar 2025 · 8 likes The useful distinction on pharmaceutical compounding rules is between what was measured and what was inferred from it. Both end up in the same sentence and only one of…
-
Scheduled maintenance and what will be unavailable Replied, post #58 · Meta › Announcements · 1 Mar 2025 · 7 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Prior authorisation: what the criteria usually require Replied, post #8 · Access › Insurance & coverage · 20 Feb 2025 · 1 like Second this, and I would have said it less carefully.
-
Triple agonism: additive, synergistic, or neither? Replied, post #17 · Compounds › Retatrutide · 9 Feb 2025 · 20 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #31 · Access › International · 6 Feb 2025 · 1 like Where I part company with post #28, and it is a narrow parting. I would put moderate confidence on the mainstream reading of Cross-border purchase within and no more.…
-
What changed in 2026, by region Replied, post #80 · Access › International · 16 Jan 2025 · 16 likes This is the sort of exchange that makes the archive worth searching.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #53 · Data & Tools › Calculators · 15 Jan 2025 · 10 likes Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads. Small point, but it is the one that…
-
Recovery when intake is low: what to cut first Replied, post #90 · Nutrition & Training › Resistance training · 15 Jan 2025 · 0 likes Taking post #87 at face value and following it one step further. The thing about recovery that took me longest to accept is that a plausible mechanism is not evidence…
-
Oxidation pathways for methionine and tryptophan Replied, post #29 · Analytics › Impurities & related substances · 28 Dec 2024 · 22 likes On oxidation pathways for methionine the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #67 · Compounds › Repair & healing peptides · 16 Nov 2024 · 19 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Reporting a discrepancy without making an allegation Replied, post #83 · Sourcing › Vendor reports · 20 Sep 2024 · 23 likes Selective submission and selective reporting are the two easiest ways for a result to be shaped, and blinding addresses the first while a commitment to post addresses…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #79 · Nutrition & Training › Hydration & electrolytes · 6 Sep 2024 · 29 likes Taking post #76 at face value and following it one step further. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #6 · Analytics › Mass spectrometry · 10 Aug 2024 · 0 likes This follows post #5 rather than contradicting it. High-resolution is a good example of a question where the honest answer is boring and the interesting answers are…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #69 · Practice › Interactions · 19 Jul 2024 · 15 likes Summarising the oral contraceptives and delayed emptying thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Cold packs, phase-change material, and what survives ten days Replied, post #90 · Sourcing › Logistics · 10 Jul 2024 · 0 likes Post #89 is the version of this I will quote in future. One addition. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…